{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:56:50Z","timestamp":1792659410431,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ijcard.2012.06.125","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T15:11:54Z","timestamp":1342624314000},"page":"2605-2610","source":"Crossref","is-referenced-by-count":18,"title":["Angiotensin converting enzyme inhibitors for prevention of new-onset type 2 diabetes mellitus: A meta-analysis of 72,128 patients"],"prefix":"10.1016","volume":"167","author":[{"given":"Deng-feng","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-mei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-de","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2012.06.125_bb0005","doi-asserted-by":"crossref","first-page":"C11","DOI":"10.2337\/diacare.21.3.C11","article-title":"Diabetes in America: epidemiology and scope of the problem","volume":"21","author":"Harris","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2337\/dc08-1296","article-title":"Full accounting of diabetes and pre-diabetes in the U.S. population in 1988\u20131994 and 2005\u20132006","volume":"32","author":"Cowie","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200003303421301","article-title":"Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis risk in communities study","volume":"342","author":"Gress","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1262-3636(07)70146-5","article-title":"Renin-angiotensin system inhibition prevents type 2 diabetes mellitus: part 1: a meta-analysis of randomised clinical trials","volume":"30","author":"Scheen","year":"2004","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2005.05.051","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"46","author":"Abuissa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0030","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2337\/diacare.28.9.2261","article-title":"The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes","volume":"28","author":"Gillespie","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.hjh.0000160198.05416.72","article-title":"Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes","volume":"23","author":"Jandeleit-Dahm","year":"2005","journal-title":"J Hypertens"},{"issue":"15","key":"10.1016\/j.ijcard.2012.06.125_bb0040","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa065061","article-title":"Effect of ramipril on the incidence of diabetes","volume":"355","author":"DREAM Trial Investigators","year":"2006","journal-title":"N Engl J Med"},{"issue":"9386","key":"10.1016\/j.ijcard.2012.06.125_bb0045","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0050","series-title":"Cochrane handbook for systematic reviews of interventions 4.2.5.","year":"2005"},{"issue":"15","key":"10.1016\/j.ijcard.2012.06.125_bb0055","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.286.15.1882","article-title":"Ramipril and the development of diabetes","volume":"286","author":"Yusuf","year":"2001","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.ijcard.2012.06.125_bb0060","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ijcard.2012.06.125_bb0065","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000054611.89228.92","article-title":"Studies of left ventricular dysfunction. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the studies of left ventricular dysfunction (SOLVD)","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ijcard.2012.06.125_bb0070","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ijcard.2012.06.125_bb0075","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"N Engl J Med"},{"issue":"9153","key":"10.1016\/j.ijcard.2012.06.125_bb0080","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"issue":"9192","key":"10.1016\/j.ijcard.2012.06.125_bb0085","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish trial in old patients with hypertension-2 study","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"issue":"9535","key":"10.1016\/j.ijcard.2012.06.125_bb0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijcard.2012.06.125_bb0095","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/hrt.2006.113084","article-title":"Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial","volume":"93","author":"Daly","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0100","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of valsartan on the incidence of diabetes and cardiovascular events","volume":"362","author":"NAVIGATOR Study Group","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0105","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1185\/030079907X188044","article-title":"The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker","volume":"23","author":"Kuti","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.ijcard.2012.06.125_bb0110","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.amjcard.2007.05.057","article-title":"A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus","volume":"100","author":"Bangalore","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0115","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","article-title":"Cardiovascular prevention and blood pressure reduction: a meta-analysis","volume":"358","author":"Staessen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0120","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","author":"Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2012.06.125_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.107.089763","article-title":"Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview","volume":"50","author":"Wang","year":"2007","journal-title":"Hypertension"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527312009163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527312009163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T03:30:58Z","timestamp":1542857458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527312009163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0167527312009163"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2012.06.125","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}